• 度胺适应症扩展后,成为FDA批准第一个也是唯一用于自体造血干细胞移植维持治疗药物。

    The expanded indication makes lenalidomide the first and only treatment to receive FDA approval for maintenance use following autologous hematopoietic stem cell transplant.

    youdao

  • 评价自体造血干细胞移植急性髓系白血病改善效果

    OBJECTIVE: to evaluate effect of autologous hematopoietic stem cell transplantation on the treatment of acute AML.

    youdao

  • 自体外周血造血干细胞PBSC移植血液系统重建与采集保存PBSC质量数量密切关系。

    The quality and quantity of peripheral blood stem cells (PBSC) are considered as an essential factor for short term and long term hematopoietic reconstruction after PBSC autograft.

    youdao

  • 研究自体造血干细胞移植(ASCT)治疗进展多发性硬化(MS)临床应用可行性免疫学改变

    Objective to research the practical feasibility of autologous stem cell transplantation (ASCT) in the treatment of progressive multiple sclerosis (MS) and its related immunological changes.

    youdao

  • 探讨自体外周血造血干细胞移植(APBSCT)对系统性红斑狼疮(SLE)患者生活质量影响

    Objective to study the effect of autologous peripheral blood stem cell transplantation (APBSCT) to the life quality of systemic lupus erythematosus (SLE) patients.

    youdao

  • 评价自体外周血造血干细胞移植PBSCT)治疗染色体异常急性白血病AL疗效

    Objective To evaluate the effect of auto-peripheral blood stem cells transplantation (PBSCT) for acute leukemia (AL) without abnormal chromosome.

    youdao

  • 方法分析8SLE自体造血干细胞移植病例移植相关并发症

    Methods Transplantation-related complications were analyzed in 8 cases of SLE treated with autologous peripheral blood stem cell transplantation.

    youdao

  • 评价自体造血干细胞移植(AHSCT)治疗恶性血液病疗效。

    Objective to evaluate the clinical outcome of autologous hemopoietic stem cell transplantation (AHSCT) for hematological malignancies.

    youdao

  • 异体造血干细胞移植相比自体移植具有重要临床应用价值。

    Compared to xenogenic hematopoietic stem cell transplantation, autogenetic transplantation is more favourable in clinical application.

    youdao

  • 科室过去年内,新诊断年轻骨髓瘤患者(65或以下)进行自体造血干细胞移植比例多少

    How many percentage of newly-diagnosed MM young patients ( <65 years old) received ASCT in your department in the half past year?

    youdao

  • 提高系统性红斑狼疮SLE自体外周造血干细胞移植风险认识。

    Objective To evaluate the clinical risk of autologous stem cell transplantation for systemic lupus erythematosus (SLE).

    youdao

  • 评价自体外周造血干细胞移植APBSCT)治疗进展型多发性硬化疗效及其安全性毒性

    Objective To assess the effects of autologous peripheral blood stem cell transplantation (APBSCT) on progressive multiple sclerosis and to obtain information on its toxicity and safety.

    youdao

  • 进行基因自体造血干细胞移植无血缘关系家庭成员捐助者以及各种疾病适应症比例在不同国家地区间差异很大。

    Use of allogeneic or autologous HSCT, unrelated or family donors for allogeneic HSCT, and proportions of disease indications varied significantly between countries and regions.

    youdao

  • 自体造血干细胞移植患者自身干细胞进行移植

    Autologous means the patient's own cells are used for the transplant.

    youdao

  • :应用自体造血干细胞移植以及体外净化骨髓技术治疗恶性实体探索肿瘤治疗方法

    Objective Purging auto bone marrow in vitro with Polyerga treating acute leukemia and solid tumor, aims at the research of effective new method of purging auto transplantation.

    youdao

  • :应用自体造血干细胞移植以及体外净化骨髓技术治疗恶性实体探索肿瘤治疗方法

    Objective Purging auto bone marrow in vitro with Polyerga treating acute leukemia and solid tumor, aims at the research of effective new method of purging auto transplantation.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定